The collaboration is a positive commercial development but lacks disclosed financial terms. Monitor future filings for order revenue recognition or expansion of the partnership to gauge materiality.
Price Chart
Executive Summary
BrainsWay announced a strategic collaboration with Inland Psychiatric Medical Group (IPMG), a Southern California behavioral health provider, including a multisystem order of Deep TMS systems and exploration of joint research projects. The filing contains no financial figures, order size, or revenue guidance, making the material impact unquantifiable.
Key Facts
- Strategic collaboration with Inland Psychiatric Medical Group (IPMG), a multi-county Southern California behavioral health provider.
- Includes a multisystem order of BrainsWay Deep TMS systems planned for installation at IPMG clinics.
- Parties will explore scientific, clinical, and research projects to expand interventional psychiatry applications.
- No financial terms, order value, or revenue projections were disclosed in the filing.
- BrainsWay Deep TMS is FDA-cleared for major depressive disorder, OCD, and smoking addiction.
Financial Impact
Undisclosed — the filing provides no order value, revenue contribution, or financial guidance.
Risk Factors
- No financial details disclosed — actual order size and revenue impact are unknown.
- Partnership may not generate material revenue if installations are delayed or limited in scope.
- Forward-looking statements subject to typical execution and market risks.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-006686 |
| Document: f6k_101926.htm | 0001171843-26-006686 |
| Document: 0001171843-26-006686-index-headers.html | 0001171843-26-006686 |
| Document: 0001171843-26-006686-index.html | 0001171843-26-006686 |
| Document: 0001171843-26-006686.txt | 0001171843-26-006686 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+60 | — | — |
Oct 21, 2026 5d ago | 6-K | $11.44 | awaiting T+60 | — | $11.21 (−2.01%) |
Oct 19, 2026 7d ago | 6-K | $11.99 | awaiting T+60 | — | $11.21 (−6.51%) |
Oct 19, 2026 7d ago | Press Release | $11.99 | awaiting T+60 | — | $11.21 (−6.51%) |
Oct 13, 2026 13d ago | 6-K | $11.92 | awaiting T+60 | — | $11.21 (−5.96%) |
Sep 8, 2026 6w ago | 6-K | $14.16 | awaiting T+60 | — | $11.21 (−20.83%) |
Aug 27, 2026 8w ago | 6-K | $14.40 | awaiting T+60 | — | $11.21 (−22.15%) |
Aug 12, 2026 10w ago | 6-K | $16.47 | awaiting T+60 | — | $11.21 (−31.94%) |
Aug 12, 2026 10w ago | 6-K | $16.60 | awaiting T+60 | — | $11.21 (−32.47%) |
Aug 12, 2026 10w ago | Press Release | $16.60 | awaiting T+60 | — | $11.21 (−32.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers